IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Pharma/fine chemicals roundup—5 February

9:59 AM MST | February 5, 2013 | Deepti Ramesh

Johnson Matthey reports lower quarterly sales Johnson Matthey reported a 2% year-on-year decrease in group sales, excluding precious metals, to £635 million ($998 million), for its fiscal third quarter ended 31 December 2012. The company announced the figures in an interim management statement. Johnson Matthey's fine chemicals division made steady progress with sales up 2%, to £63 million. Operating profit increased slightly compared with the year-earlier quarter but was lower than in the previous quarter, the company says. Lonza restructures...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa